I just went back and read the RGL prospectus.Interestingly, in the independent's report (5.7 from memory) RGL had a budget of $200K for the Cambodian projects for 2017, 2018 which was mostly to keep on care and maintenance until the leases were approved ... at which time they were going to look for a JV partner.
So, since the prospectus back in 2017 the applications have been pending ...
- Forums
- ASX - By Stock
- RGL
- Ann: Ceasing to be a substantial holder
Ann: Ceasing to be a substantial holder, page-8
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGL (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
0.001(16.7%) |
Mkt cap ! $8.467M |
Open | High | Low | Value | Volume |
0.8¢ | 0.8¢ | 0.7¢ | $259.8K | 34.17M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 4299526 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 6686426 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 4299526 | 0.007 |
22 | 7999263 | 0.006 |
37 | 15681851 | 0.005 |
13 | 7299444 | 0.004 |
11 | 13946667 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 6686426 | 13 |
0.009 | 6945497 | 15 |
0.010 | 3739626 | 9 |
0.011 | 3192850 | 7 |
0.012 | 185635 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
RGL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online